인간 제대혈의 CD14+ 단핵구 세포 및 CD34+ 조혈모세포에서 유래된 수지상세포의 특성 비교 = Comparison of characteristics of Dendritic Cells derived from CD 14+ Monocyte and CD34+ Hematopoietic Stem Cell in Human Umbilical Cord Blood

다국어 초록 (Multilingual Abstract)

Objective: To compare the morphological, phenotypical, and functional characteristics of dendritic cells (DCs) generated from two precursor cell sources (CD 14+ monocyte and CD34+ hematopoietic stem cell) of human umbilical cord blood (UCB) under identical ex vivo generation conditions and to determine the best cellular source for DCs-based anticancer immunotherapy. Methods: CD14+ monocytes and CD34+ hematopoietic stem cells were isolated from human UCB and induced to differentiate into DCs under identical culture conditions using granulocyte macrophage colony stimulating factor (800 U/mL) and IL-4 (500 U/mL). Then maturation of DCs was induced with IFN-γ (1000 U/mL) and LPS (1 ㎍/mL). Morphology was compared with confocal microscopy and phenotypical analysis was done with FACS. The level of IL-12p70 production was determined with ELISA kit and T cell proliferation capacity was assessed with mixed lymphocyte reaction (MLR). Results: Eight-day-old mature DCs from CD14+ monocytes or CD34+ hematopoietic stem cells had identical morphology. Flow cytometric analysis revealed that CD14+ monocyte-derived DCs (M-DCs) and CD34+ hematopoietic stem cell-derived DCs (CD34-DCs) showed similar enhanced expression of CD80, CD83, and CD86 (P>0.05). The level of IL-12p70 production was significantly higher in mature DCs (8-day-old) than immature DCs (6-day-old) of either source (P<0.05), but it was significantly highly elevated in CD34-DCs (P<0.05). DCs of both precursors showed potent stimulation capacity in MLR, with CD34-DCs having a maximum effect at 1:2 ratio and M-DCs at 1:20 ratio, although CD34-DCs had significantly greater proliferative effects at all ratios (P<0.05). Conclusion: These findings suggest that CD34-DCs may be a more attractive source for DC-based immunotherapy. But because of morphologic, phenotypical, and functional similarities between the two cellular sources, both are good sources for generating DCs and one is not superior to the other. Thus cellular availability could be an important factor in determining DC-generation protocol to be used if all other issues are equal. Further comparative testing for these two precursors is in need.

참고문헌 (Reference)

1 "The dendritic cell system and its role in immunogenicity" 9 : 271-96, 1991

2 "The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro" 90 : 229-37, 1992

3 "Searching for unrelated donor hematopoietic stem cells:availability and speed of umbilical cord blood versus bone marrow" 8 : 257-260, 2002

4 "Results of unrelated umbilical cord blood hematopoietic stem cell transplant" 8 : 146-154, 2001

5 "Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor" 333 : 1038-1044, 1995

6 "Phenotypic alterations and IL- 1beta production in CD34(+) progenitor- and monocyte-derived dendritic cells after exposure to allergens: a comparative analysis" 294 : 109-116, 2002

7 "Origin, maturation and antigen presenting function of dendritic cells" 9 : 10-16, 1997

8 "New insights into the mobilization and phagocytic activity of dendritic cells" 183 : 1287-1292, 1996

9 "Maturation stages of mouse dendritic cells in growth factor- dependent long-term cultures" 185 : 317-328, 1997

10 "Immunobiology of dendritic cells" 18 : 767-811, 2000

11 "Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells" 86 : 3828-32, 1989

12 "Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors" 344 : 1815-1822, 2001

13 "Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA- identical sibling Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources" 342 : 1846-1854, 2000

14 "Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application" 223 : 1-15, 1999

15 "Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony- stimulating factor" 176 : 1693-702, 1992

16 "Generation of dendritic cells from human bone marrow mononuclear cells:advantages for clinical application in comparison to peripheral blood monocyte derived cells" 20 : 247-253, 2002

17 "Generation of dendritic cells from fresh and frozen cord blood CD34+ cells" 37 : 362-371, 1998

18 "Generation of antigen- specific CD8+ CTLs from naive precursors" 153 : 996-1003, 1994

19 "GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells" 360 : 258-61, 1992

20 "Expansion of Immunostimulatory Dendritic Cells from Peripheral Blood of Patients with Cancer" 2 : 65-69, 1997

21 "Effects of cytokines on the culture and differentiation of dendritic cells in vitro" 10 : 43-51, 2001

22 "Effect of interleukin-7 on the in vitro development and maturation of monocyte derived human dendritic cells" 51 : 361-371, 2000

23 "Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes in the presence of different serum supplements" 238 : 119-131, 2000

24 "Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy" 3 : 19-29, 2001

25 "Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells" 163 : 3597-3604, 1999

26 "Dendritic cells as the terminal stage of monocyte differentiation" 160 : 4587-4595, 1998

27 "Dendritic cells and their emerging clinical applications" 33 : 479-492, 2001

28 "Dendritic cells and the control of immunity" 392 : 245-252, 1998

29 "Dendritic cells (I) Biological functions" 46 : 9-19, 2001

30 "Dendritic cells" 72 : 255-324, 1999

31 "Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells" 75 : 18-33, 2003

32 "Clinical and experimental uses of umbilical cord blood" 32 : 601-609, 2002

33 "CD34+ peripheral blood progenitor cell and monocyte derived dendritic cells:a comparative analysis" 99 : 490-499, 1997

34 "CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis" 90 : 1458-1470, 1997

35 "CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner" 163 : 4869-4877, 1999

36 "A closed and single-use system for monocyte enrichment:potential for dendritic cell generation for clinical applications" 43 : 481-487, 2003